Is meningococcal B vaccination needed in the post-COVID-19 world?

Area of Science:

• Epidemiology
• Infectious Diseases
• Public Health

Background:

• Neisseria meningitidis is a primary cause of bacterial meningitis globally, spread via respiratory droplets.
• Meningitis poses significant public health challenges due to high rates of illness, death, and epidemic potential.
• Serogroup B meningococcal infections present ongoing challenges, with limited vaccine inclusion in national programs.

Purpose of the Study:

• To present epidemiological data on meningococcal disease.
• To discuss factors contributing to the complexity of preventing bacterial and viral infections.

Main Methods:

• Review of epidemiological data on meningococcal disease.
• Discussion of existing studies on pathogen interactions and prevention.

Main Results:

• Sustained Neisseria meningitidis serogroup B infections observed during the COVID-19 pandemic.
• Increased meningococcal disease incidence noted post-pandemic control.
• Evidence suggests respiratory viruses can enhance susceptibility to bacterial respiratory infections.

Conclusions:

• Serogroup B meningococcal disease remains a critical public health concern requiring improved prevention strategies.
• The interplay between viral and bacterial respiratory infections complicates prevention efforts.
• Further research is needed to understand and address the intricate factors influencing the prevention of both bacterial and viral infections.